Home |
Free Dividend Report |
Stock Splits Calendar |
OCX Historical Stock Prices |
Preferred Stock Newsletter |
OCX Options Chain |
Stock Message Boards |
Oncocyte (OCX) has the following price history information. Looking back at OCX historical stock prices for the last five trading days, on April 19, 2024, OCX opened at $2.54, traded as high as $2.55 and as low as $2.49, and closed at $2.50. Trading volume was a total of 53.90K shares. On April 22, 2024, OCX opened at $2.52, traded as high as $2.56 and as low as $2.49, and closed at $2.51. Trading volume was a total of 62.90K shares. On April 23, 2024, OCX opened at $2.45, traded as high as $2.55 and as low as $2.45, and closed at $2.46. Trading volume was a total of 22.80K shares. On April 24, 2024, OCX opened at $2.51, traded as high as $2.51 and as low as $2.29, and closed at $2.46. Trading volume was a total of 40.60K shares. On April 25, 2024, OCX opened at $2.45, traded as high as $2.49 and as low as $2.35, and closed at $2.44. Trading volume was a total of 26.30K shares.
OCX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Oncocyte shares, starting with a $10,000 purchase of OCX, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 01/05/2016 | |
End date: | 04/25/2024 | |
Start price/share: | $202.20 | |
End price/share: | $2.44 | |
Dividends collected/share: | $0.00 | |
Total return: | -98.79% | |
Average Annual Total Return: | -41.24% | |
Starting investment: | $10,000.00 | |
Ending investment: | $120.72 | |
Years: | 8.31 |
OCX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/19/2024 | $2.54 | $2.55 | $2.49 | $2.50 | 53.90K |
04/22/2024 | $2.52 | $2.56 | $2.49 | $2.51 | 62.90K |
04/23/2024 | $2.45 | $2.55 | $2.45 | $2.46 | 22.80K |
04/24/2024 | $2.51 | $2.51 | $2.29 | $2.46 | 40.60K |
04/25/2024 | $2.45 | $2.49 | $2.35 | $2.44 | 26.30K |
About Oncocyte |
Oncocyte is a precision diagnostics company focused on developing and commercializing proprietary tests in three areas: DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies, VitaGraft is a blood-based solid organ transplantation monitoring test and DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. |
OCX Historical Closing Prices | |
Date | Close |
04/19/2024 | $2.50 |
04/22/2024 | $2.51 |
04/23/2024 | $2.46 |
04/24/2024 | $2.46 |
04/25/2024 | $2.44 |
Healthcare Historical Prices |
OCX is categorized under the Healthcare sector; below are some other companies in the same sector:
ODT Historical Stock Prices
Free OCX Email Alerts:
|
OCX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.